A legislative committee yesterday adopted a resolution demanding that Academia Sinica President Wong Chi-huey (翁啟惠) return to Taiwan from the US as soon as possible to clear up a controversy in connection with alleged insider trading of a pharmaceutical company’s shares.
If Wong cannot return to Taiwan immediately, he should submit a written report to the Legislative Yuan’s Education and Culture Committee within one week, the resolution said.
He is required to deliver an oral report to the committee within one week of his return, it added.
Photo: Chu Pei-hsiung, Taipei Times
Wong, who is in the US for academic activities, had earlier said that he would return to Taiwan to attend a hearing on the case scheduled for yesterday.
On Tuesday, he called President Ma Ying-jeou (馬英九) to express his intention to resign from his post as head of the nation’s highest academic institution, citing health reasons, and tendered his written resignation on Wednesday.
Ma rejected Wong’s resignation and instructed him to return to Taiwan as soon as possible to report to him and the legislature, according to Presidential Office spokesman Charles Chen (陳以信).
Photo: Chien Jung-fong, Taipei Times
Academia Sinica is under the direct administrative supervision of the Presidential Office.
The controversy flared up following Wong’s endorsement of a new cancer drug by publicly listed biotech company OBI Pharma Inc (台灣浩鼎), even though the company announced on Feb. 21 that the drug had failed second and third-round clinical trials, news that sent the company’s stock price plunging.
Wong is a biochemist considered to be an expert on the theory behind OBI Pharma’s cancer drug.
On March 3, Wong issued a statement through Academia Sinica that he did not hold any shares in Taiwan’s biotech companies.
However, Next Magazine reported on Wednesday last week that Wong’s daughter, Wong Yu-shioh (翁郁秀), obtained 3 million OBI Pharma shares in 2012 at the price of NT$31 per share before it was listed on the emerging stock market.
The company was listed on the over-the-counter market at NT$310 per share the following year.
The revelation fueled accusations against Wong Chi-huey of a conflict of interests and possible insider trading.
An initial investigation found that Wong Yu-shioh sold more than 10,000 of her OBI Pharma shares three months before the announcement of the cancer drug’s trial failure.
Wong Chi-huey yesterday penned a letter addressed to his Academia Sinica colleagues.
“My personal affairs have lately became the subject of public controversy, with an impact on our institution’s reputation that is profoundly disturbing to me. I am currently abroad and physically indisposed, and I am therefore unable to attend our March 30 report to the Legislative Yuan,” he said in the letter. “I had tendered my resignation to the president and will, upon concluding my affairs abroad, immediately return [to Taiwan] to make an explanation [about this affair].”
“I will continue in the future to dedicate my professional knowledge to science and biotechnological research in Taiwan,” he added.
The US Department of State yesterday criticized Beijing over its misrepresentation of the US’ “one China” policy in the latest diplomatic salvo between the two countries over a bid by Taiwan to regain its observer status at the World Health Assembly, the decisionmaking body of the WHO. “The PRC [People’s Republic of China] continues to publicly misrepresent U.S. policy,” Department of State spokesman Ned Price wrote on Twitter. “The United States does not subscribe to the PRC’s ‘one China principle’ — we remain committed to our longstanding, bipartisan one China policy, guided by the Taiwan Relations Act, Three Joint Communiques, and
FATES LINKED: The US president said that sanctions on Russia over Ukraine must exact a ‘long-term price,’ because otherwise ‘what signal does that send to China?’ US President Joe Biden yesterday vowed that US forces would defend Taiwan militarily in the event of a Chinese attack in his strongest statement to date on the issue. Beijing is already “flirting with danger,” Biden said following talks with Japanese Prime Minister Fumio Kishida in Tokyo, in which the pair agreed to monitor Chinese naval activity and joint Chinese-Russian exercises. Asked if Washington was willing to get involved militarily to defend Taiwan, he replied: “Yes.” “That’s the commitment we made,” Biden said. “We agreed with the ‘one China’ policy, we signed on to it ... but the idea that it can be
SUBTLE? While Biden said the US policy of ‘strategic ambiguity’ on Taiwan had not changed, the group targeted China and Russia without naming them Leaders of Australia, India, Japan and the US yesterday warned against attempts to “change the status quo by force,” as concerns grow about whether China could invade Taiwan. The issue of Taiwan loomed over a leadership meeting in Tokyo of the Quadrilateral Security Dialogue (Quad) nations — the US, Japan, Australia and India — who stressed their determination to ensure a free and open Indo-Pacific region in the face of an increasingly assertive China, although Japanese Prime Minister Fumio Kishida said the group was not targeting any one country. The four leaders said in a joint statement issued after their talks
Nearly half of Taiwanese believe President Tsai Ing-wen (蔡英文) has not done enough to prepare the nation against Chinese aggression, the a poll released yesterday by the Taiwanese Public Opinion Foundation showed. Asked whether the Tsai administration’s military and non-military preparations to defend Taiwan are adequate, 30.6 percent said they were “mostly inadequate” and 18.9 percent said they “very inadequate,” while 25.7 percent said they were “mostly adequate” and 7.1 percent said they were “very adequate.” Another 17.6 percent had no opinion or did not know enough to form a judgement. Still, 51 percent of respondents approved of Tsai’s national defense policy,
RSS